I am a clinical academic working in the University of Oxford's Transplantation Research Immunology Group and the Oxford Kidney and Transplant Unit, Churchill Hospital. 

My main area of research is in the use of clinical and immunological biomarkers to predict long-term transplant outcomes; particularly the development of de novo malignancy post-transplant. Ultimately, the aim is to use these biomarkers in order to personalise immunosuppressive regimens to improve long-term outcomes.  This has led particularly an interest in the role of 'immune ageing' (immunosenescence) and the impact upon immune responses in the clinical setting.